HUM Humana Inc.

Humana and the National Quality Forum Publish Population Health Paper in the New England Journal of Medicine

Physician leaders from Humana Inc. (NYSE: HUM) and the National Quality Forum (NQF) explore the impact that social, behavioral and environmental factors – such as access to healthy foods, safe environments and social support – can have on physical and mental health and why these aspects need to be incorporated into payment models. The findings were published today in the New England Journal of Medicine (NEJM) in a titled “Clinical and Social Risk Adjustment – Reconsidering Distinctions.”

This press release features multimedia. View the full release here:

The paper, which is co-authored by William H. Shrank, M.D., M.S.H.S., Chief Medical Officer, Humana, and Shantanu K. Agrawal, M.D., Mphil, President and CEO, National Quality Forum, argues for evaluating social risk adjustment alongside clinical risk in population-based payment models, to provide incentives for addressing health-related social needs to improve health outcomes, rather than lowering the standards for their care.

“Growing evidence indicates that socially disadvantaged people have comparatively worse health outcomes suggesting that clinical and social risk are related,” said Dr. Agrawal, “To improve the health outcomes of all people, including the disadvantaged, we must consider this growing body of evidence as part of a comprehensive, 21st century approach to risk adjustment.”

A focus on upstream causes of poor health have been an emphasis of more recent value-based reimbursement models, with the goal of preventing disease and keeping patients healthy. The analysis and recommendations in the NEJM article build on a recent NQF and Humana collaboration, . The guide highlights that social needs such as food insecurity and social isolation can lead to or worsen serious chronic conditions.

Crisis situations, such as COVID-19, can also create new social needs gaps and worsen those already present. Early on the coronavirus pandemic indicates that the virus’s toll is particularly hard on historically disadvantaged and others facing challenges with social determinants of health.

Population health strategies must address these social needs, due to the downstream health impacts these cause and especially during a time of crisis, according to Dr. Shrank. “The COVID-19 crisis has underscored the inter-relatedness of social context and physical health,” said Dr. Shrank. “Our proactive outreach to our COVID-19-positive and highest risk members has uncovered high rates of social isolation and considerable barriers to accessing healthy food, which put them at higher risk for bad outcomes. Given the associations between social risk and clinical risk, it stands to reason that risk adjustment for payment models should incorporate the breadth of patient characteristics that predict the need for health care services.”

In addition to social needs, these individuals have also faced systemic barriers to accessing health care services and engaging in preventative health behaviors, leading to a higher prevalence of conditions such as diabetes and hypertension. The presence of these underlying chronic conditions has led to worse outcomes for COVID-19 patients.

For more information about Humana’s efforts to address the impact of social needs, especially among people living with multiple chronic conditions, please visit .

About Humana

Humana Inc. is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at , including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most recent investor conference presentations
  • Quarterly earnings news releases and conference calls
  • Calendar of events
  • Corporate Governance information

About the National Quality Forum

The National Quality Forum (NQF) works with members of the healthcare community to drive measurable health improvements together. NQF is a not-for-profit, membership-based organization that gives all healthcare stakeholders a voice in advancing quality measures and improvement strategies that lead to better outcomes and greater value. Learn more at .

EN
23/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Humana Inc.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 17, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Humana Inc: 1 director

Two Directors at Humana Inc bought 7,133 shares at between 0.000USD and 229.247USD. The significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...

Moody’s Ratings rates Humana’s senior notes Baa2; outlook negative

New York , March 3, 2025 – Moody's Ratings (Moody's) has assigned a Baa2 senior unsecured debt rating to Humana Inc.'s (Humana, NYSE: HUM, senior debt at Baa2) planned issuance of up to $1.25 billion of senior unsecured notes due in 2035 and 2055. The net proceeds of this transaction are for general...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch